Literature DB >> 17273999

Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells.

Frank Schmitz1, Antje Heit, Simone Guggemoos, Anne Krug, Jörg Mages, Matthias Schiemann, Heiko Adler, Ingo Drexler, Tobias Haas, Roland Lang, Hermann Wagner.   

Abstract

Activation of interferon regulatory factor (IRF)-3 and/or IRF-7 drives the expression of antiviral genes and the production of alpha/beta IFN, a hallmark of antiviral responses triggered by Toll-like receptors (TLR). Here we describe a novel antiviral signaling pathway operating in myeloid (m) dendritic cells (DC) and macrophages that does not require IRF-3 and/or IRF-7 but is driven by IRF-1. IRF-1 together with myeloid differentiation factor 88 (MyD88) or IL-1 receptor-associated kinase (IRAK)-1 triggered IFN-beta promoter activation. IRF-1 physically interacted with MyD88 and activation of mDC via TLR-9 induced IRF-1-dependent IFN-beta production paralleled by rapid transcriptional activation of IFN-stimulated genes. The NF-kappaB-dependent production of pro-inflammatory cytokines, however, was not influenced by IRF-1. TLR-9 signaling through this pathway conferred cellular antiviral resistance while IRF-1-deficient mice displayed enhanced susceptibility to viral infection. These results demonstrate that TLR-9 activation of mDC and macrophages contributes to antiviral immunity via IRF-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273999     DOI: 10.1002/eji.200636767

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  49 in total

Review 1.  Innate immune signaling in defense against intestinal microbes.

Authors:  Melissa A Kinnebrew; Eric G Pamer
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 2.  Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion.

Authors:  Søren Jensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

3.  Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells.

Authors:  Giuseppe Mancuso; Maria Gambuzza; Angelina Midiri; Carmelo Biondo; Salvatore Papasergi; Shizuo Akira; Giuseppe Teti; Concetta Beninati
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

Review 4.  The roles of TLRs, RLRs and NLRs in pathogen recognition.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Int Immunol       Date:  2009-02-26       Impact factor: 4.823

Review 5.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

6.  DNA Sensing in the Innate Immune Response.

Authors:  Benoit Briard; David E Place; Thirumala-Devi Kanneganti
Journal:  Physiology (Bethesda)       Date:  2020-03-01

7.  The central adaptor molecule TRIF influences L. sigmodontis worm development.

Authors:  Anna Wiszniewsky; Manuel Ritter; Vanessa Krupp; Sandy Schulz; Kathrin Arndts; Heike Weighardt; Samuel Wanji; Achim Hoerauf; Laura E Layland
Journal:  Parasitol Res       Date:  2019-01-15       Impact factor: 2.289

8.  Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.

Authors:  Stephane Daffis; Melanie A Samuel; Mehul S Suthar; Brian C Keller; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

9.  Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9.

Authors:  Dane Parker; Alice Prince
Journal:  J Immunol       Date:  2012-09-07       Impact factor: 5.422

10.  Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7.

Authors:  Stephane Daffis; Mehul S Suthar; Kristy J Szretter; Michael Gale; Michael S Diamond
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.